ACROMETA GROUP LIMITED (43F)
Outcome of Regulatory Review:
Outcome of Regulatory Review:
TWO Provides Update on UWMC Engagement Following Expiration of Waiver Period
A New Press Release from Elicio Therapeutics
Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview
Select Surface Samples Up to 44.5% TREO at Shiloh; Drill Results Highlight Laterally Extensive Monazite-Bearing Sands System Potential
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
Pasithea Therapeutics Announces Exhibit atChildren’s Tumor Foundation 2026 NF Conference
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
Change - Change in Corporate Information: Liquidation of Indirect Wholly-Owned Subsidiaries